Search

everythinglearnresearchcommunity

for

Search:↓

Systemic steroids temporarily improve severe alopecia areata in children but often lead to relapse.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

New treatments for hair loss are being developed using molecular biology.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Anti-CD19 therapy may help treat SLE and NMOSD.

Skin problems are very common in people with systemic lupus erythematosus and important for diagnosis.

New treatments for lupus show promise, but more research is needed, especially for children.

Mixed Connective Tissue Disease can develop from overlapping symptoms of several autoimmune diseases, making diagnosis complex.

Catatonia can be a rare sign of lupus, needing careful diagnosis and treatment.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Trans-esophageal echocardiography is crucial for accurately diagnosing heart issues in lupus patients.

Early recognition and management of gastrointestinal tuberculosis in lupus patients are crucial to prevent complications.

Correct diagnosis is crucial for treating overlapping conditions like NMOSD and SLE effectively.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Effective treatments for lichen planopilaris are unclear due to inconsistent results and a lack of strong research evidence.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Hair loss in teenagers is hard to treat and lacks a cure, with some treatments available depending on the type of hair loss.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

Methotrexate treats various disorders by inhibiting DNA synthesis, but careful monitoring is needed to avoid toxicity and manage side effects.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Effective treatment with antiparasitic, antibacterial, anti-inflammatory, and antiallergic medications can lead to recovery in dogs with complicated demodicosis.

The document explains various skin conditions and their treatments.